MENU

Table of Contents

The Role of CellmaEHR in Neonatal and Paediatrics: Safer and Smarter Care

EHR in neonatal and paediatrics

Help Others Discover – Click to Share!

Facebook
Twitter
LinkedIn

Table of Contents

Newborn and child healthcare in the UK is facing increasing pressures. According to the Office for National Statistics (ONS, 2023), the neonatal mortality rate in England and Wales stands at 3.0 deaths per 1,000 live births, while infant mortality remains at 3.9 per 1,000 live births. Despite advancements in clinical practice, around 70% to 80% of all infant deaths occur during the neonatal period. Babies born before 24 weeks though fewer than 0.1% of births, accounted for 37.4% of neonatal deaths, with a mortality rate of 782.2 per 1,000 live births in this group. The National Child Mortality Database (2024) reported a child mortality rate of 29.8 deaths per 100,000 among children aged 0–17 years, underscoring persistent challenges in paediatric healthcare delivery. 
 
Hospital pressures also remain high, with over 829,000 emergency admissions of children under 18 recorded across the UK in 2023–24. These figures reflect the ongoing demand for efficient, integrated systems to manage neonatal and paediatric care, where accurate data, timely interventions, and cross-departmental communication are crucial for improving outcomes. 

Aligned with the NHS 10 Year Plan for virtual wards and neighbourhood care teams the CellmaEHR provides neonatal and paediatric care outside the four walls of a hospital. Cellma brings together maternal-baby records, NICU flowsheets, and outpatient paediatric workflows to create continuity of care across multiple care settings. The platform supports “structured” data capture for national datasets and reporting e.g., MSDS, Neonatal Data Set (NNRD), HES/SUS datasets, and helps to enable interoperability via the FHIR UK Core and SNOMED CT standards. For hospitals striving to provide fully integrated, safer care and meeting NHS aspirations, CellmaEHR in neonatal and paediatrics is not simply a clinical tool; it is a key partner in the delivery of care. 

Integrations and Standards Utilised by Cellma 

CellmaEHR has been developed to ensure that all aspects comply with UK healthcare standards, while integrating easily with existing hospital systems: 
 
National Standards & Terminologies: FHIR UK Core for interoperability, SNOMED CT for clinical terminology, LOINC for labs, ICD-10/OPCS for coding. 
 
NHS Spine / GP Connect: Enabling access to summary patient data, patient demographics and coordination of discharge. 
 
Electronic Prescription Service (EPS): Dosing workflows for child discharge prescriptions. 
 
Laboratory and Imaging Systems: Bidirectional integration with laboratory information systems (LIS), picture archiving and communication systems (PACS), radiology information systems (RIS) and any laboratory or imaging systems. 
 
Pharmacy and Blood Bank Systems: Drug reconciliations, neonatal drug library, medications tracked through infusion pumps, tracked by batches, or lots. 
 
Device and Bedside Integration: Receipt of real time device data from monitoring equipment, ventilators and infusion pumps using HL7 or FHIR streams. 
 
Public Health & Screening Services: Automatically capturing and reporting newborn bloodspot screening, hearing screening, and retinopathy of prematurity (ROP) screening. 
 
Data submissions & research: MSDS, Neonatal Data Set (NNRD), HES/SUS, & ONS reporting, including field-level validation. 
 
Security & privacy compliance: the GDPR, Data Security & Protection Toolkit (DSPT), & Caldicott principles and processes including role-based access, encryption, audit logs, & pseudonymisation for secondary research purpose. 
 
Parent and Care Coordination Portals: Regulated access to the records & assessments with consent to comply with the neonatal aspects. 
 
Through these specifications and integrations, CellmaEHR provides trustworthy, secure, and future-proof Electronic Health Records for neonates and paediatrics, supporting a single care ecosystem for modern hospitals and the NHS.  

Clinical Scope: Neonatal and Paediatric Care

Population / Area 

Data & Features 

Neonates (delivery room, SCBU, NICU, transitional care) 

– Gestational & corrected age tracking, birth weight, APGAR scores, maternal linkage- Hourly/daily vitals, ventilator parameters, oxygen/CPAP settings, nutrition management (breastmilk, donor milk, parenteral nutrition)- Weight-based medication dosing with pump/infusion integration, transfusion tracking, lab results integration- Screening: bloodspot, hearing, congenital heart, ROP exams 

Paediatrics (children & young people, outpatient, ward, PICU) 

– Growth & development tracking (birth to 18 years), vaccination history, allergy documentation, PEWS scoring- Structured lab & imaging orders with SNOMED CT-coded problem lists- Safeguarding & social risk flags 

Challenges Addressed 

– Fragmented systems, data gaps, and alert fatigue- Resolved by Cellma EHR through maternal–baby linkage, device feeds, weight-based dosing alerts, and configurable clinical decision support tailored to neonatal and paediatric physiology 

Core Features of CellmaEHR 

Cellma’s platform can address the clinical, operational and compliance challenges within hospitals:  
 
Clinical Documentation and Flowsheets: Minute to minute neonatal flowsheets and paediatric ward templates with structured problem lists and configurable order sets.  
 
Drug Interaction: Weight and age-driven medication dosing engine, unique drug library for neonates, barcode medication administration (BCMA), and infusion pump interoperability.  
 
Order Entry & Results: Computerised Physician Order Entry (CPOE) that integrates with lab, imaging, and microbiology results. 
 
Device & Bedside Integration: Providing accurate documentation with live HL7/FHIR feeds from monitors, ventilators, and infusion pumps.  
 
Care Coordination: Involving maternal-baby links, discharge messaging to GPs/health visitors, and parental portals that can only be accessed through consent.  
 
Dashboards & Analytics: Including live NICU occupancy, tracking of ventilators, PEWS escalation for sick babies and planned extracts to send data to NNRD, HR-XML, HES/SUS, and MSDS. 

AI & NLP Intelligence in Cellma – Cellma uses AI and NLP to analyse clinical notes, detect risks early, and support accurate decision-making in neonatal and paediatric care. 
 
By linking all these modules together, Cellma alleviates burdensome administration, improves data quality for audits, and maximises staff attention on patients rather than paperwork. 

Security and compliance

Cellma complies with all UK legal and NHS obligations, including GDPR compliance, DSP Toolkit compliance, and adopting the Caldicott principles. Sensitive neonatal and paediatric data are protected, with end-to-end encryption, role-based access control, audit record with logs, and multi-factor authentication. Cellma also uses pseudonymisation and secure extraction tools for safe secondary use of information for research and benchmarking. 

Why choosing Cellma is the right choice 

No matter if you are a NICU nurse or paediatric consultant, efficiency for staff and safety for patients is the most important aspect. CellmaEHR:  
 

  • Helps you spend less time calculating doses or retrieving historical records. 
  • Allows you to report accurately to national datasets. 
  • Easily integrates into virtual wards and neighbourhood care centres. 
  • Provides clinical alerts that are relevant to neonatal and paediatrics physiology. 
     

An EHR in neonatal and paediatrics is not just a digital medical record but building a connected ecosystem for the whole journey of care, from the delivery room to home care follow-ups. 
 
In an increasing clinically complex and regulated environment, CellmaEHR delivers a clinically sound, secure and intelligent clinical solution to be used in the baby and children patient population, whilst improving safer outcomes, better reporting of data and staff experience, in line with NHS expectations. 

FAQs

What neonatal-specific features does Cellma support?

Cellma offers neonatal-specific capabilities, including gestational and corrected age tracking, APGAR scores, mother / baby record linkage, integration of ventilators and infusion devices, and support for weight-based medication dosing. Cellma captures mandated neonatal screening results as well, allowing the provision of safe, accurate, and compliant care within the NICU and SCBU. 

What are the benefits of using Cellma for paediatric care from birth into adolescence?

Cellma allows for growth and development tracking, immunisation history, allergy management, and PEWS scoring for children and young people allowing for structured laboratory and imaging requests to be coded with SNOMED CT, as well as incorporating safeguarding and social risk triggers to support holistic care provision for paediatric patients up to 18 years of age.

What is Cellma's solution to the challenges of broken systems in neonatal and paediatric care?

Cellma's capability to link maternal and baby records, and integrate with medical devices/lab data, provides configurable clinical decision support, alleviates alert fatigue, reduces data gaps, and ultimately creates a safer workflow for clinicians while providing a comprehensive view of patient care across neonatal and paediatric populations.